Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.56 |
| ▸ | CTSD | P07339 | 6/20 | 0.51 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7377290 | 1.00 | REN (0.56) | RENCTSDELANECTSBCTSS | |
| SCHEMBL7351566 | 0.99 | REN (0.57) | RENCTSDELANECTSBCTSS | |
| SCHEMBL7351550 | 0.99 | REN (0.57) | RENCTSDELANECTSBCTSS | |
| SCHEMBL7345250 | 0.89 | CTSB (0.54) | RENCTSBCTSSCTSK | |
| SCHEMBL9439832 | 0.89 | CTSB (0.54) | RENCTSBCTSSCTSK | |
| SCHEMBL9439828 | 0.89 | CTSB (0.54) | RENCTSBCTSSCTSK | |
| SCHEMBL9439843 | 0.89 | CTSB (0.54) | RENCTSBCTSSCTSK | |
| SCHEMBL7358144 | 0.83 | REN (0.54) | RENCTSDELANEBACE1 | |
| SCHEMBL7358156 | 0.83 | REN (0.61) | RENCTSDELANE | |
| SCHEMBL9294998 | 0.81 | REN (0.54) | RENCTSDELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5338726-A | Hypotensive agents, antiulcer agents | ABBOTT LABORATORIES (US) | 1994-08-16 | — | — | US | disclosed |
| WO-1992013545-A1 | ENDOTHELIN CONVERTING ENZYME INHIBITORS | ABBOTT LABORATORIES (US) | 1992-08-20 | — | — | WO | disclosed |